Veradermics
MANE | NYSE
$129.53
-$10.16 (-7.27%)
At close: Nov 2, 2026, 4:00 PM ET
$139.72
+$0.03 (+0.02%)
Pre-market:
Nov 2, 2026, 9:24 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|---|---|
PE Ratio | -57.45 | -40.48 | -49.67 | n/a | -1.17K |
PEG Ratio | 2.09 | -7.69 | n/a | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 6.11 | 6.02 | -11.65 | n/a | 139.04 |
P/FCF Ratio | -63.47 | -36.95 | -33.05 | n/a | -2.09K |
P/OCF Ratio | -63.49 | -36.95 | -33.06 | n/a | -2.09K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | n/a | 0 | 0 | n/a |
Quick Ratio | 70.53 | 59.12 | 16.66 | 3.29 | 11.77 |
Current Ratio | 70.53 | 59.12 | 16.66 | 3.29 | 11.77 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | -43.25 | n/a | -20.45 |
Return on Equity | -2.89% | -6.95% | 18.05% | 20.94% | -10.35% |
Return on Assets | -2.85% | -6.83% | -14.31% | -106.95% | -9.53% |
Return on Invested Capital | -3.63% | -7.62% | -16.04% | -155.29% | -10.92% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MANE